Table 3 18 genes chosen for further study based on breast cancer relevance
From: Global profiling of prolactin-modulated transcripts in breast cancer in vivo
| Â | Unigene | Symbol | Gene descriptor | Fold Change |
|---|---|---|---|---|
1 | Hs.89626 | PTHrP | parathyroid hormone-like hormone | 11.9 |
2 | Hs.46468 | CCR6 | chemokine (C-C motif) receptor 6 | 4.9 |
3 | Hs.76095 | IER3 | immediate early response 3 | 3.4 |
4 | Hs.121520 | AMIGO2 | amphoterin induced gene 2 | 3.3 |
5 | Hs.115263 | EREG | epiregulin | 3.2 |
6 | Hs.436186 | ERAP1 | type 1 tumor necrosis factor receptor shedding aminopeptidase regulator | 3.0 |
7 | Hs.417962 | DUSP4 | dual specificity phosphatase 4 | 2.7 |
8 | Hs.8257 | CISH | cytokine inducible SH2-containing protein | 2.6 |
9 | Hs.145807 | TMC5 | transmembrane channel-like 5 | 2.5 |
10 | Hs.270833 | AREG | amphiregulin (schwannoma-derived growth factor) | 2.4 |
11 | Hs.418138 | FN1 | fibronectin 1 | 2.3 |
12 | Hs.102541 | NTN4 | netrin 4 | 2.2 |
13 | Hs.1145 | WT1 | Wilms tumor 1 | 2.1 |
14 | Hs.80409 | GADD45A | growth arrest and DNA-damage-inducible, alpha | 1.8 |
15 | Hs.404081 | FGFR2 | fibroblast growth factor receptor 2 | 1.8 |
16 | Hs.155024 | BCL6 | B-cell CLL/lymphoma 6 | −2.8 |
17 | Hs.357901 | SOX4 | SRY (sex determining region Y)-box 4 | −2.0 |
18 | Hs.415048 | FLT4 | fms-related tyrosine kinase 4 | −2.0 |